Skip to Main Content
Skip Nav Destination






(skoe POL a meen)

Brand Names: US

  • Transderm Scop (1.5 MG) [DSC]
  • Transderm-Scop

Therapeutic Category

  • Anticholinergic Agent
  • Anticholinergic Agent, Transdermal

Medication Safety Issues

Older Adult: High-Risk Medication:

Beers Criteria: Scopolamine is identified in the Beers Criteria as a potentially inappropriate medication to be avoided in patients 65 years and older (independent of diagnosis or condition) due to its highly anticholinergic properties and uncertain effectiveness as an antispasmodic (Beers Criteria [AGS 2019]).

Pharmacy Quality Alliance (PQA): Scopolamine is identified as a high-risk medication in patients 65 years and older on the PQA’s Use of High-Risk Medications in the Elderly (HRM) performance measure, a safety measure used by the Centers for Medicare and Medicaid Services (CMS) for Medicare plans (PQA 2017).

Other safety concerns:

Transdermal patch may contain conducting metal (eg, aluminum); remove patch prior to MRI.

This item requires a subscription. For full access to this content, please log in to an existing user account or purchase an individual subscription. If you have an active subscription and appear logged in (your name appears in the upper right corner), but you cannot access content, please click the “Log Out” option under your name and log back in.
Close Modal

or Create an Account

Close Modal
Close Modal